Corvus Pharmaceuticals Announces Data from Cohort 2 of Placebo-Controlled Phase 1 Clinical ...
NDAQ:CRVS) Corvus Pharmaceuticals Announces Data from Cohort 2 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib ...
Le Lézard5 天
Genascence Announces Six-Month Results from Phase 1b DONATELLO Trial Indicating GNSC-001 ...
Genascence Corporation ("Genascence"), a clinical-stage biotechnology company revolutionizing the treatment of prevalent musculoskeletal diseases with ...